MicroRNA-23a-3p improves traumatic brain injury through modulating the neurological apoptosis and inflammation response in mice
Related Experiment Video
Updated: Jan 2, 2026

Electromagnetic Controlled Closed-Head Model of Mild Traumatic Brain Injury in Mice
Published on: September 28, 2022
Zhikun Li1, Ruijun Xu1, Xiaodong Zhu1
1Department of Orthopedic Surgery, TongRen Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
Abstract:
Secondary brain damage plays an important role in Traumatic brain injury (TBI) and inhibition of this damage has benefit for TBI treatment. However, the pathogenesis of secondary brain damage remains largely unknown. Here, we tried to explore the influence of microRNAs (miRNAs) on neuron apoptosis and inflammatory response after TBI. Firstly, the miRNA expression profiles were analyzed in the cerebral cortex tissues from the TBI mice model (controlled cortical impact) using miRNA microarray. miR-23a-3p (miR-23a) attracted our attention as its suppressive effects on apoptosis and inflammation. The further results showed that miR-23a upregulation improved long-term neurological function, the neuron apoptosis, and inhibited neuroinflammation, whereas knockdown of miR-23a had an opposite result. Using etoposide-induced primary cortical neurons injury model, we found that miR-23a was decreased in this cell model and miR-23a overexpression-suppressed etoposide induced the activity of caspase 3 and the releases of inflammatory mediators in primary cortical neurons. Phosphatase and tensin homolog (PTEN), a well‑known regulator of the AKT/mTOR pathway, was found to be a direct target of miR‑23a in the primary cortical neurons. Most importantly, it was found that miR-23a overexpression reactivated the AKT/mTOR pathway in TBI mice model, as demonstrated by the upregulation of phosphorylated (p‑)AKT and p‑mTOR. Taken together, these data indicate that miR-23a may serve as a therapeutic target for the treatment of TBI.
Insights
MicroRNAs (miRNAs) like miR-23a show promise in treating traumatic brain injury (TBI). Upregulating miR-23a reduces neuron apoptosis and inflammation, improving neurological function after TBI.
Area of Science:
- Neuroscience
- Molecular Biology
Background:
- Secondary brain damage significantly impacts Traumatic Brain Injury (TBI) outcomes.
- The precise mechanisms driving secondary brain damage are not fully understood.
- MicroRNAs (miRNAs) are implicated in cellular processes relevant to TBI pathogenesis.
Purpose of the Study:
- To investigate the role of specific miRNAs in neuron apoptosis and inflammation following TBI.
- To identify potential miRNA-based therapeutic targets for TBI treatment.
Main Methods:
- Differential gene expression analysis of miRNAs in a TBI mouse model (controlled cortical impact).
- In vitro studies using etoposide-induced primary cortical neuron injury models.
- Validation of miRNA targets and signaling pathway activation (AKT/mTOR).
Main Results:
- miR-23a was identified as a key miRNA with suppressive effects on apoptosis and inflammation.
- Upregulation of miR-23a improved neurological function, reduced neuron apoptosis, and inhibited neuroinflammation in TBI mice.
- miR-23a directly targets PTEN, modulating the AKT/mTOR pathway and reducing caspase-3 activity and inflammatory mediator release in neurons.
Conclusions:
- miR-23a plays a protective role against secondary brain damage in TBI.
- Restoring miR-23a levels may represent a novel therapeutic strategy for TBI.
- The miR-23a/PTEN/AKT/mTOR axis is a critical pathway in TBI pathogenesis and treatment.

